Figure 4
From: Blood-borne miRNA profile-based diagnostic classifier for lung adenocarcinoma
Validation analysis of resultant diagnostic classifier using independent cohort of samples from healthy subjects (HS) and patients with lung adenocarcinoma (AD), as well as patients with benign pulmonary disease (BPD) and various other types of cancer.
(a) Assessment of diagnostic classifier using an independent cohort. Ave. of HS, average of voting sum in HS. (b) ROC curve for validation cohort consisting of samples from 52 healthy subjects and 110 patients with lung adenocarcinoma. (c) ROC curve for discriminating patients with lung adenocarcinoma from either healthy subjects and patients with pulmonary lung disease. (d) Assessment of diagnostic classifier according to disease stage in lung adenocarcinoma cases. (e) Assessment of diagnostic classifier in other types of cancer.
